Therapeutic Role of Mir-19A/19b in Cardiac Regeneration and Protection from Myocardial Infarction

Feng Gao,Masaharu Kataoka,Ning Liu,Tian Liang,Zhan-Peng Huang,Fei Gu,Jian Ding,Jianming Liu,Feng Zhang,Qing Ma,Yingchao Wang,Mingming Zhang,Xiaoyun Hu,Jan Kyselovic,Xinyang Hu,William T. Pu,Jian'an Wang,Jinghai Chen,Da-Zhi Wang
DOI: https://doi.org/10.1038/s41467-019-09530-1
IF: 16.6
2019-01-01
Nature Communications
Abstract:The primary cause of heart failure is the loss of cardiomyocytes in the diseased adult heart. Previously, we reported that the miR-17-92 cluster plays a key role in cardiomyocyte proliferation. Here, we report that expression of miR-19a/19b, members of the miR-17-92 cluster, is induced in heart failure patients. We show that intra-cardiac injection of miR-19a/19b mimics enhances cardiomyocyte proliferation and stimulates cardiac regeneration in response to myocardial infarction (MI) injury. miR-19a/19b protected the adult heart in two distinctive phases: an early phase immediately after MI and long-term protection. Genome-wide transcriptome analysis demonstrates that genes related to the immune response are repressed by miR-19a/19b. Using an adeno-associated virus approach, we validate that miR-19a/19b reduces MI-induced cardiac damage and protects cardiac function. Finally, we confirm the therapeutic potential of miR-19a/19b in protecting cardiac function by systemically delivering miR-19a/19b into mice post-MI. Our study establishes miR-19a/19b as potential therapeutic targets to treat heart failure.
What problem does this paper attempt to address?